These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2882247)

  • 41. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 2006 Aug; 81(34/35):331-40. PubMed ID: 16933380
    [No Abstract]   [Full Text] [Related]  

  • 42. Japanese encephalitis immunization in South Korea: past, present, and future.
    Sohn YM
    Emerg Infect Dis; 2000; 6(1):17-24. PubMed ID: 10653564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Increase attention to vaccination against Japanese encephalitis].
    Friman G; Proos L; Trolin I; Böttiger M; Lundbergh P
    Lakartidningen; 1992 Nov; 89(46):3918, 3921. PubMed ID: 1334183
    [No Abstract]   [Full Text] [Related]  

  • 44. Side-effects with Japanese encephalitis vaccine.
    Andersen MM; Rønne T
    Lancet; 1991 Apr; 337(8748):1044. PubMed ID: 1673198
    [No Abstract]   [Full Text] [Related]  

  • 45. [Japanese B encephalitis--incidence, clinical picture and prevention in travelers to Eastern Asia].
    Stenbeck JL
    Lakartidningen; 1979 Aug; 76(35):2893-5. PubMed ID: 228131
    [No Abstract]   [Full Text] [Related]  

  • 46. Japanese Encephalitis Among Three U.S. Travelers Returning from Asia, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(27):737-40. PubMed ID: 19609246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety & efficacy of Japanese encephalitis vaccine produced in India.
    Rao Bhau LN; Singh G; Gowal D; Saxena SN; Kobayashi M; Oya A; Yoshioka I
    Indian J Med Res; 1988 Oct; 88():301-7. PubMed ID: 2852169
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunization for children traveling abroad.
    Sood SK
    Pediatr Clin North Am; 2000 Apr; 47(2):435-48, viii. PubMed ID: 10761513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccinating against Japanese encephalitis virus: what have we learned from recent clinical trials?
    Dubischar-Kastner K; Kanesa-Thasan N
    Expert Rev Vaccines; 2012 Oct; 11(10):1159-61. PubMed ID: 23176646
    [No Abstract]   [Full Text] [Related]  

  • 50. Low uptake of Japanese encephalitis vaccination among Australian travellers.
    Mills DJ; Lau CL; Furuya-Kanamori L
    J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33313831
    [No Abstract]   [Full Text] [Related]  

  • 51. Japanese encephalitis: a Chinese solution?
    Steinhoff MC
    Lancet; 1996 Jun; 347(9015):1570-1. PubMed ID: 8667861
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunogenicity of low dose Japanese encephalitis vaccine (BIKEN) administered by the intradermal route: preliminary data.
    Intralawan P; Paupunwatana S
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):79-83. PubMed ID: 8216563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO
    Amicizia D; Zangrillo F; Lai PL; Iovine M; Panatto D
    J Prev Med Hyg; 2018 Mar; 59(1):E99-E107. PubMed ID: 29938245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Japanese encephalitis vaccination in Thailand.
    Fukunaga T; Rojanasuphot S; Wungkorbkiat S; Thammanichanon A; Kan T
    Biken J; 1974 Mar; 17(1):21-31. PubMed ID: 4368852
    [No Abstract]   [Full Text] [Related]  

  • 55. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children.
    Xin YY; Ming ZG; Peng GY; Jian A; Min LH
    Am J Trop Med Hyg; 1988 Aug; 39(2):214-7. PubMed ID: 2841880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
    Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Pancharoen C; Boaz M; Bouckenooghe A; Feroldi E
    Vaccine; 2016 Nov; 34(46):5664-5669. PubMed ID: 27686833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series.
    Gambel JM; DeFraites R; Hoke C; Brown A; Sanchez J; Karabatsos N; Tsai T; Meschievitz C
    J Infect Dis; 1995 Apr; 171(4):1074. PubMed ID: 7706798
    [No Abstract]   [Full Text] [Related]  

  • 58. Anaphylaxis to Japanese encephalitis vaccine.
    Sakaguchi M; Nakashima K; Takahashi H; Nakayama T; Fujita H; Inouye S
    Allergy; 2001 Aug; 56(8):804-5. PubMed ID: 11488694
    [No Abstract]   [Full Text] [Related]  

  • 59. Japanese encephalitis vaccine in travellers. Is wider use prudent?
    Jelinek T; Nothdurft HD
    Drug Saf; 1997 Mar; 16(3):153-6. PubMed ID: 9098653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccines against Japanese encephalitis.
    Bhau LN; Saxena SN
    J Commun Dis; 1989 Mar; 21(1):75-80. PubMed ID: 2553796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.